Source:http://linkedlifedata.com/resource/pubmed/id/17230419
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-1-18
|
pubmed:abstractText |
C1 esterase inhibitor (C1inh) is a major inhibitor of several pathways of inflammation in humans. In this study, we show that virulent-phase cultures of Bordetella pertussis, the etiological agent for whooping cough, but not other Bordetella species specifically recruit C1inh from human serum. Using a spontaneous mutant of B. pertussis that was deficient in C1inh binding, we demonstrate that the ability of B. pertussis to acquire high levels of human C1inh and wild-type levels of serum resistance are well correlated, suggesting that, in addition to and independent of BrkA expression, acquisition of C1inh is vital to B. pertussis resistance to complement-mediated killing.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
195
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
585-8
|
pubmed:meshHeading |
pubmed-meshheading:17230419-Bordetella pertussis,
pubmed-meshheading:17230419-Complement C1 Inactivator Proteins,
pubmed-meshheading:17230419-Complement System Proteins,
pubmed-meshheading:17230419-Humans,
pubmed-meshheading:17230419-Mutation,
pubmed-meshheading:17230419-Protein Binding,
pubmed-meshheading:17230419-Virulence
|
pubmed:year |
2007
|
pubmed:articleTitle |
Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing.
|
pubmed:affiliation |
Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|